Metagenomics and Personalized Medicine

Slides:



Advertisements
Similar presentations
The Microbiome: What’s the immune system got to do with it?
Advertisements

Virus-Plus-Susceptibility Gene Interaction Determines Crohn's Disease Gene Atg16L1 Phenotypes in Intestine Ken Cadwell, Khushbu K. Patel, Nicole S. Maloney,
Volume 2, Issue 2, Pages (August 2007)
Inflamm Intest Dis 2016;1: DOI: /
Sex-Specific Aging in Flies, Worms, and Missing Great-Granddads
Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era  Geoffrey A. Preidis, James.
Volume 145, Issue 2, Pages (August 2013)
Update on primary sclerosing cholangitis
Novel SIRT1 Mutation Linked to Autoimmune Diabetes in Humans
Targeting the Human Microbiome With Antibiotics, Probiotics, and Prebiotics: Gastroenterology Enters the Metagenomics Era  Geoffrey A. Preidis, James.
Tooth Be Told, Genetics Influences Oral Microbiome
Interleukin-18: The Bouncer at the Mucosal Bar
Cellular Origin of Androgen Receptor Pathway-Independent Prostate Cancer and Implications for Therapy  W. Nathaniel Brennen, John T. Isaacs  Cancer Cell 
Metagenomics and Personalized Medicine
The Fungal Mycobiota: Small Numbers, Large Impacts
David R. Meldrum, M. D. , Marge A. Morris, M. Ed. , R. D. , C. D. E
Mammalian PGRPs Also Mind the Fort
Through the Scope Darkly: The Gut Mycobiome Comes into Focus
John A Todd, Linda S Wicker  Immunity 
Arturo Casadevall, Liise-anne Pirofski  Cell Host & Microbe 
Endosomes as Platforms for NOD-like Receptor Signaling
Inflammatory Bowel Disease as a Model for Translating the Microbiome
Octavio Ramilo, Asunción Mejías  Cell Host & Microbe 
Metabolic Phenotyping in Health and Disease
Cellular Origin of Androgen Receptor Pathway-Independent Prostate Cancer and Implications for Therapy  W. Nathaniel Brennen, John T. Isaacs  Cancer Cell 
Unraveling the Pros and Cons of Interferon-γ Gene Regulation
Psychiatric Disorders: Diagnosis to Therapy
Pathogenic Escherichia coli in inflammatory bowel diseases
The Intestinal Immune System in Obesity and Insulin Resistance
Volume 36, Issue 1, Pages 2-14 (October 2009)
Volume 141, Issue 3, Pages (September 2011)
D'oh! Genes and Environment Cause Crohn's Disease
Florian T. Merkle, Kevin Eggan  Cell Stem Cell 
Volume 139, Issue 6, Pages (December 2010)
Advances and Perspectives in the Genetics of Inflammatory Bowel Diseases  Mathias Chamaillard, Razvan Iacob, Pierre Desreumaux, Jean–Frederic Colombel 
The Human Microbiome and Obesity: Moving beyond Associations
Arturo Casadevall, Liise-anne Pirofski  Cell Host & Microbe 
The Virome in Host Health and Disease
Etiology of Type 1 Diabetes
Microbes, Microbiota, and Colon Cancer
Psychiatric Disorders: Diagnosis to Therapy
David R. Meldrum, M. D. , Marge A. Morris, M. Ed. , R. D. , C. D. E
Volume 78, Issue 1, Pages 1-3 (April 2013)
Maya Saleh, Charles O. Elson  Immunity 
ILC1 Populations Join the Border Patrol
Interleukin-18: The Bouncer at the Mucosal Bar
Role of the Microbiota in Immunity and Inflammation
Constitutive Antiviral Immunity at the Expense of Autoimmunity
Translating Inflammatory Bowel Disease Research into Clinical Medicine
Estrogen Receptor Transrepresses Brain Inflammation
Evan G. Williams, Johan Auwerx  Cell 
Viral Safeguard: The Enteric Virome Protects against Gut Inflammation
Volume 141, Issue 7, Pages (June 2010)
Dan R. Littman, Eric G. Pamer  Cell Host & Microbe 
Recognizing Macrophage Activation and Host Defense
Autophagy, Immunity, and Microbial Adaptations
Volume 2, Issue 2, Pages (August 2007)
Norovirus Regulation by Host and Microbe
The Human Gut Microbiome: From Association to Modulation
Volume 14, Issue 3, Pages (September 2013)
Inflaming the CD8+ T Cell Response
Route Connection: Mouth to Intestine in Colitis
GWAS Meets TCGA to Illuminate Mechanisms of Cancer Predisposition
Genetic Factors and the Intestinal Microbiome Guide Development of Microbe-Based Therapies for Inflammatory Bowel Diseases  Louis J. Cohen, Judy H. Cho,
Even Neurons Are Excited by Th17 Cells
Pneumococcus Adapts to the Sickle Cell Host
Cooperative Microbial Tolerance Behaviors in Host-Microbiota Mutualism
Human Microbiota-Associated Mice: A Model with Challenges
Cellular Alchemy and the Golden Age of Reprogramming
Host and Microbes Date Exclusively
Presentation transcript:

Metagenomics and Personalized Medicine Herbert W. Virgin, John A. Todd  Cell  Volume 147, Issue 1, Pages 44-56 (September 2011) DOI: 10.1016/j.cell.2011.09.009 Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 1 Perfect Storms for Developing Crohn's Disease and Type 1 Diabetes A series of overlapping events and phenotypes driven by metagenetic and environmental processes that, in sum, contribute to the development and pathogenesis of type 1 diabetes (A) and Crohn's disease (B). Cell 2011 147, 44-56DOI: (10.1016/j.cell.2011.09.009) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 2 Refining the Relationship between Genotype and Phenotype in Complex Inflammatory Diseases (A) Traditionally, a disease is considered as a single phenotype, with genes or loci conferring risk to two diseases shown as overlapping in a Venn diagram. (B) We propose a new view of the genotype-phenotype relationship in which different sets of loci are responsible for mechanistically distinct subtypes of diseases, and the sum of these subtypes constitutes the overall diagnosis. Here two disease subtypes are indicated for simplicity, but many such subtypes may exist, and sets of overlapping risk loci may be associated with these multiple mechanistically distinct disease phenotypes. Cell 2011 147, 44-56DOI: (10.1016/j.cell.2011.09.009) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 3 The Iterative Redefinition of Mechanism-Based Disease Subtypes Here we present a conceptual workflow for breaking a broad disease diagnosis into its component subtypes by the iterative application of genetics and mechanistic studies. One output would be therapeutics based on disease subtype and patient stratification into groups more likely to respond to a given therapy or preventive strategy (A). (B) shows specific challenges for this process for type 1 diabetes and Crohn's disease. Cell 2011 147, 44-56DOI: (10.1016/j.cell.2011.09.009) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 4 Microbe Plus Gene Interactions Determine Inflammatory Bowel Disease Phenotypes (A) Two recent studies analyzed the capacity of two different strains of murine norovirus, MNV strain CR6 versus MNV strain CW3, to trigger phenotypes when orally inoculated into mice with a mutation in the Crohn's disease risk gene Atg16L1 (Cadwell et al., 2008, 2010). This mutation results in decreased expression of Atg16L1 protein (hypomorphic, Atg16L1HM). Even though MNV CW3 and MNV CR6 are closely related, they have different effects on intestinal pathology in Atg16L1HM mice. Some of these interactions are observed only when mice are fed the chemical dextran sodium sulfate (DSS). (B) Two other studies analyzed the capacity of two different species of Bacteroides to trigger phenotypes in combination with mutations in the IL-10 receptor and T cell expression of a dominant-negative form of the TGF-β receptor (dnKO mice) (Bloom et al., 2011; Kang et al., 2008). dnKO mice are cured of their spontaneous colitis by treatment with antibiotics, but oral feeding of “cured” mice with fecal contents or specific bacteria reinduces disease. Even though Bacteroides thetaiotaomicron and Bacteroides sp. TP5 are closely related, they induce different forms of inflammation when fed to antibiotic-cured dnKO mice. In the same studies, dysbiosis (Box 1) with increases in the numbers of Enterobacteriaceae was noted in dnKO mice prior to curing the mice with antibiotics. However, E. coli inoculation did not trigger the pathologies seen with either Bacteroides species. Cell 2011 147, 44-56DOI: (10.1016/j.cell.2011.09.009) Copyright © 2011 Elsevier Inc. Terms and Conditions

Figure 5 A Metagenetic View of Developing Normal and Pathological Immune Responses This flowchart depicts stages in the development of normal immune responses or autoimmune and inflammatory diseases at which metagenetic interactions (i.e., gene-gene and gene-microbe interactions) might play a determining role. “Microbial products” refers to molecules that interact with host innate immune sensors and initiate inflammation. Cell 2011 147, 44-56DOI: (10.1016/j.cell.2011.09.009) Copyright © 2011 Elsevier Inc. Terms and Conditions